Central African Republic vs Niger: Treatment coverage for schistosomiasis
Central African Republic
13.9%
in 2024
Niger
35.1%
in 2024
Central African Republic rank
39th
Niger rank
36th
Treatment coverage for schistosomiasis over time
- Central African Republic
- Niger
How they compare
Niger currently reports 35.1% against 13.9% in Central African Republic, a difference of 21.2%.
That makes Niger's figure about 2.5 times Central African Republic's.
Across all 10 years both countries report, Niger has been ahead every year.
Central African Republic ranks 39th and Niger ranks 36th of 45 countries.
Niger has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Central African Republic | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.4% | 12.4% | 7.9% | Niger |
| 2010s | 21.1% | 77.4% | 56.3% | Niger |
| 2020s | 17.6% | 50.4% | 32.8% | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Central African Republic or Niger?
- Niger, at 35.1% against 13.9% in Central African Republic as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Central African Republic and Niger?
- 21.2%, with Niger ahead.
- How many years of comparable data are there for Central African Republic and Niger?
- 10 years are reported by both, from 2009 to 2024.
- How do Central African Republic and Niger rank globally for treatment coverage for schistosomiasis?
- Central African Republic ranks 39th and Niger ranks 36th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) – with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.